
Jeevan Scienti. Sees Revision in Market Assessment Amid Mixed Financial Signals
2025-12-05 10:10:46Jeevan Scienti., a microcap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting nuanced changes across key financial and technical parameters. Despite persistent challenges in profitability and valuation, recent market activity and technical indicators have contributed to a shift in the company’s overall assessment.
Read MoreAre Jeevan Scienti. latest results good or bad?
2025-11-13 19:33:26Jeevan Scientific's latest financial results for Q2 FY26 present a complex picture of operational performance. The company reported net sales of ₹12.38 crores, reflecting an 8.60% year-on-year growth, which indicates some level of stabilization after a challenging previous quarter. However, this revenue growth is overshadowed by a significant decline in profitability, with a consolidated net loss of ₹0.09 crores, marking a stark contrast to the profit levels seen in the same quarter last year. The operating margin stood at 16.72%, which, while showing a sequential recovery from a negative margin in the prior quarter, represents a notable contraction from the 21.93% achieved in Q2 FY24. This decline in margins is indicative of rising operational costs, particularly in employee expenses, which have outpaced revenue growth. The profit after tax margin has also diminished sharply to just 0.08%, down from 2.19%...
Read More
Jeevan Scientific Technology Shows Improved Financial Stability Amid Operational Challenges
2025-11-13 11:01:09Jeevan Scientific Technology has shown improved financial stability in its latest quarter, with operating cash flow reaching Rs 10.07 crore. However, challenges persist, including a decline in profit after tax and low inventory and debtors turnover ratios. The company has outperformed the Sensex in recent market performance.
Read More
Jeevan Scientific Q2 FY26: Marginal Recovery Masks Deeper Profitability Crisis
2025-11-13 09:21:54Jeevan Scientific Technology Ltd., a clinical contract research organisation, reported a consolidated net loss of ₹0.09 crores in Q2 FY26, marking a dramatic reversal from the ₹0.24 crores profit recorded in the same quarter last year. The micro-cap healthcare services company, with a market capitalisation of ₹98.17 crores, saw its stock trade at ₹62.00 following the results, reflecting a modest 0.26% gain as investors grappled with the company's persistent profitability challenges despite a sequential improvement in revenue.
Read MoreHow has been the historical performance of Jeevan Scienti.?
2025-11-13 00:15:24Answer: The historical performance of Jeevan Scienti shows a fluctuating trend in key financial metrics over the years. Breakdown: Jeevan Scienti's net sales have seen a rise from 36.18 Cr in Mar'23 to 46.84 Cr in Mar'25, although they peaked at 67.79 Cr in Mar'22. The total operating income followed a similar pattern, increasing to 46.84 Cr in Mar'25 from 39.65 Cr in Mar'24, yet it remains below the 67.79 Cr recorded in Mar'22. The company's operating profit (PBDIT) has improved significantly, reaching 8.06 Cr in Mar'25 from 5.29 Cr in Mar'24, but it is still a decline from the 22.67 Cr in Mar'22. Profit before tax has shown a recovery to 0.05 Cr in Mar'25 from a loss of 1.60 Cr in Mar'24, while profit after tax also returned to a positive figure of 0.06 Cr in Mar'25, compared to a loss of 1.33 Cr in the previous year. The total assets of the company increased to 77.37 Cr in Mar'25 from 66.95 Cr in Mar'24...
Read MoreWhen is the next results date for Jeevan Scienti.?
2025-11-10 23:16:25Jeevan Scienti. will declare its results on 12 November 2025....
Read MoreWhy is Jeevan Scienti. falling/rising?
2025-11-07 22:43:55As of 07-Nov, Jeevan Scientific Technology Ltd's stock price is currently at Rs 60.00, reflecting a decline of Rs 2.83, or 4.5%. The stock has underperformed its sector by 4.16% today and opened with a loss of 3.39%. It reached an intraday low of Rs 60, indicating significant selling pressure. Additionally, the stock's delivery volume has decreased by 9.68% compared to the 5-day average, suggesting a drop in investor participation. Over the past week, the stock has seen a decline of 7.64%, contrasting with a positive return of 49.93% over the past month, indicating recent volatility. Unfortunately, there is no information available regarding positive or negative factors that could provide further insight into the stock's recent movement. Broader market context shows that while Jeevan Scientific Technology Ltd has experienced a strong return of 21.09% year-to-date and 12.99% over the past year, its recent p...
Read MoreWhy is Jeevan Scienti. falling/rising?
2025-10-31 22:26:42As of 31-Oct, Jeevan Scientific Technology Ltd is experiencing a price increase, currently at Rs 64.00, which reflects a rise of 0.93 or 1.47%. The stock has been performing well, having gained 7.4% over the last three days and is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock is close to its 52-week high, being only 4.53% away from Rs 66.9. The stock has shown impressive returns over various periods, including an 80.33% increase over the past month, significantly outperforming the Sensex, which has only risen by 3.65% in the same timeframe. Furthermore, there has been a notable increase in investor participation, with delivery volume rising by 12.2% compared to the 5-day average. In the broader market context, Jeevan Scientific Technology Ltd's short-term performance is particularly strong when compared to the Sensex, which has seen a decli...
Read MoreWhy is Jeevan Scienti. falling/rising?
2025-10-24 22:28:58As of 24-Oct, Jeevan Scientific Technology Ltd's stock price is currently at Rs 60.13, reflecting a decline of Rs 3.16 or 4.99%. The stock has been underperforming, having lost 7.44% over the last two days and opening with a loss of 2.02% today. Despite a strong performance over the past month with a 69.91% increase, the stock has recently faced downward pressure, as indicated by its current price being lower than the 5-day moving averages, although it remains above the longer-term moving averages. Additionally, while there has been a rise in investor participation with a notable increase in delivery volume, the stock's performance today has underperformed its sector by 4.6%. There is no information available regarding positive or negative factors that could further clarify the stock's recent movement. Broader market context shows that while Jeevan Scientific Technology Ltd has experienced a significant in...
Read MoreAnnouncement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
12-Nov-2025 | Source : BSEDisclosure under Regulation 30 read with schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for alteration in the Memorandum of Association of the Company.
Shareholder Meeting / Postal Ballot-Scrutinizers Report
12-Nov-2025 | Source : BSEScrutiniser report for the EGM held on 12.11.2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 12.11.2025
12-Nov-2025 | Source : BSEOutcome of the Board Meeting held on 12.11.2025
Corporate Actions
No Upcoming Board Meetings
Jeevan Scientific Technology Ltd has declared 12% dividend, ex-date: 21 Sep 22
No Splits history available
No Bonus history available
No Rights history available






